Taisuke Ikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taisuke Ikawa has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Kazuo Yano
Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
2 shared publications - Masayuki Yamato
Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan
2 shared publications - Natsumi Watanabe
Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
2 shared publications - Hiroshi Kasanuki
Research Institute for Science and Engineering, Waseda University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-866, Japan
1 shared publication - Ken Masamune
Faculty of Advanced Techno-Surgery, Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan
1 shared publication - Kenichiro Tsuyuki
Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-866, Japan
1 shared publication
Latest Publications
- Open Access
- 1 June 2015
- Published by Elsevier in Regenerative Therapy
- Vol. 1, 98-108
Non-clinical assessment design of autologous chondrocyte implantation products
- 1 June 2015
- Published by Elsevier in Regenerative Therapy
- Vol. 1, 98-108
Open AccessNon-clinical assessment design of autologous chondrocyte implantation products
- Open Access
- 1 June 2015
- Published by Elsevier in Regenerative Therapy
- Vol. 1, 45-56
Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
- 1 June 2015
- Published by Elsevier in Regenerative Therapy
- Vol. 1, 45-56
Open AccessRegulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan